These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 268450)

  • 1. [Clinical significance of cationic proteins of leukocyte lysosomes: cationic leukocyte antigen (CLA) as a marker of blast crisis in chronic myelocytic leukaemia (author's transl)].
    Tischendorf FW; Wüst I; Tischendorf MM
    Klin Wochenschr; 1977 Jul; 55(14):685-93. PubMed ID: 268450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative estimation of cationic leukocyte antigen (cla) and lysozyme in leukaemic leukocytes (author's transl)].
    Böhm HR; Tischendorf FW
    Klin Wochenschr; 1978 Jan; 56(2):61-7. PubMed ID: 75285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myelocytic leukaemia presenting in blastic transformation. Two cases primarily diagnosed as acute myelocytic leukaemia.
    Worm AM; Pedersen-Bjergaard J
    Scand J Haematol; 1977 Apr; 18(4):288-91. PubMed ID: 266270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic determination of the massive excretion of "cationic leukocyte antigen" (CLA) in the urine of patients with chronic myeloses in terminal blastic crisis].
    Tischendorf FW; Wüst I; Clemens MR; Wilms K; Tischendorf MM
    Med Lab (Stuttg); 1976 Sep; 29(9):206-12. PubMed ID: 1068339
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Auer bodies and Ph1 chromosome: chronic myeloid pseudoleukemia?].
    Mayer S; Falkenrodt A; Albert A; Audhuy B; Stoll C; Uettwiller F; Oberling F; Bergerat JP
    Nouv Rev Fr Hematol (1978); 1982; 24(5):307-12. PubMed ID: 6300758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of alkaline leucocyte phosphatase in hematology (author's transl)].
    Pont J; Reimer EE
    Wien Med Wochenschr; 1979 Mar; 129(5):136-9. PubMed ID: 285525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukocyte alkaline phosphatase and glucose-6-phosphate-dehydrogenase of the erythrocytes in differential diagnosis of chronic myeloproliferative diseases (author's transl)].
    Hennemann HH; Schief A
    Med Klin; 1974 Aug; 69(34):1359-63. PubMed ID: 4530151
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.
    Gangal SG; Damle NK; Khare AG; Advani SH
    Br J Cancer; 1979 Sep; 40(3):391-6. PubMed ID: 292450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukocyte glycosaminoglycans in various forms of myelo- and lymphoproliferative blood diseases].
    Kharchenko MF; Shatskaia TL; Shcherbakova EG; Abdulkadyrov KM
    Vopr Onkol; 1986; 32(10):47-53. PubMed ID: 3465089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
    Takasaki Y; Robinson WA; Tan EM
    J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative value of isozymes of amino acid naphthylamidase in the diagnosis of myeloid leukemias.
    Roos G; Sinna GA; Björkstén B; Lenner P; Lundgren E
    Cancer; 1980 Jul; 46(2):325-9. PubMed ID: 6930322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The blood histamine level in differential and early diagnosis of chronic myelocytic leukemia].
    Gingold N
    Wien Z Inn Med; 1968; 49(5):180-6. PubMed ID: 5261000
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic granulocytic leukaemia.
    Baikie AG
    Med J Aust; 1974 Jul; 2(1):12-7. PubMed ID: 4528473
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunological classification of leukaemia based on a rapid microcytotoxicity test.
    Billing RJ; Foon KA; Linker-Israeli M
    Clin Exp Immunol; 1982 Jul; 49(1):142-8. PubMed ID: 6957278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blast crisis mimicking acute leukaemia as first manifestations of chronic myelogenous leukaemia. Report of three cases (author's transl)].
    Cervantes F; Rozman C; Ballesta F; Brugues R; Grañena A; Montserrat E; Nomdedeu B
    Sangre (Barc); 1981; 26(1):96-103. PubMed ID: 6942521
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical, cytochemical and immunological characteristics of the blast crisis in myelocytic leukemia].
    Vygovskaia IaI; Loginskiĭ VE; Shnitsar EV; Mazurok AA
    Ter Arkh; 1983; 55(8):26-30. PubMed ID: 6579695
    [No Abstract]   [Full Text] [Related]  

  • 20. [The significance of muramidase (lysozyme) determinations in hematologic diseases].
    Mets T; Carlier A; Van Hove W
    Ned Tijdschr Geneeskd; 1976 Nov; 120(47):2039-44. PubMed ID: 1070575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.